References
1. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucosetolerancein U.S. Adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21:518–524, 1998.
2. Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22: 312–318.
3. Epidemiology of Ischemic Stroke in Patients With Diabetes, BRETT M. KISSELA, MD1 JANE KHOURY, MS2 DAWN KLEINDORFER.
4. The Impact of History of Hypertension and Type 2 Diabetes at Baseline on the Incidence of Stroke and Stroke Mortality Gang Hu, PhD; Cinzia Sarti, PhD; Pekka Jousilahti, PhD; Markku Peltonen, PhD; Qing Qiao, PhD; Riitta Antikainen, PhD; Jaakko Tuomilehto, PhD
5. Lehto S, Ro¨nnemaa T, Pyo¨ra¨la¨ K, Laakso M. Predictors of stroke in middle-aged patients with non–insulin-dependent diabetes. Stroke. 1996; 27:63–68.
6. The global burden of cerebrovascular disease Thomas Truelsen, Stephen Begg , Colin Mathers
7. Sex Differences in Stroke Epidemiology A Systematic Review Peter Appelros, MD, PhD; Birgitta Stegmayr, PhD; Andreas Tere´nt, MD, PhD
8. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996; 27:63–68.
9. Davis TM, Millns H, Stratton IM, Holman RR, Turner RC. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med. 1999;159:1097–1103.
10. Iso H, Imano H, Kitamura A, Sato S, Naito Y, Tanigawa T, Ohira T, Yamagishi K, Iida M, Shimamoto T. Type 2 diabetes and risk of nonembolicischaemic stroke in Japanese men and women. Diabetologia. 2004;47:2137–2144.
11. Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, Miller R, Ewing I, Moomaw CJ, Szaflarski JP, Gebel J, Shukla R, Broderick JP. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005;28:355–359.
12. Risk factors for stroke in type 2 diabetes mellitus NAILYA ASFANDIYAROVA, NINA KOLCHEVA, IGOR RYAZANT-SEV, VLADIMIRRYAZANTSEV
13. Multiple modifiable risk factors for first ischemic stroke: a population-based epidemicological study D. I. Hadjieva, P. P. Minevab and M. I. Vukova aMedical University, Sofia, Bulgaria; and bMedical Faculty, Thracian University, StaraZagora, Bulgaria
14. Sacco RL, Benjamin EJ, Broderick JP, et al. American Heart Association Prevention Conference IV: prevention and rehabilitation of stroke: risk factors. Stroke. 1997;28:1507±1517.
15. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352: 854–865.
16. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interven-tions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653.
17. Joint National Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413±2446.
18. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
19. American Diabetes Association. Clinical practice recommendations 1998. Diabetes Care. 1998;21(suppl 1):S1±S89.
20. Primary Prevention of Ischemic Stroke Larry B. Goldstein, MD, Chair; Robert Adams, MD; Kyra Becker, MD; Curt D. Furberg, MD; Philip B. Gorelick, MD.
21. Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibril-lation. Chest. 1998;114(suppl):579S-589S.
22. Joint National Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413±2446.
23. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273: 402±407.
24. Building a “brain attack” team to administer thrombolytic therapy for acute ischemic stroke Michael D. Hill,* Phillip A. Barber,* Andrew M. Demchuk,* Robert J. Sevick,† Nancy J. Newcommon, *Teri Green,* Alastair M. Buchan*
25. Acute Intravenous–Intra-Arterial Revas-cularization Therapy for Severe Ischemic Stroke Michael D. Hill, MD; Philip A. Barber, BM; Andrew M. Demchuk, MD; Nancy J. Newcommon, MN; Andrea Cole-Haskayne, RN.
26. Risk factors for stroke in type 2 diabetes mellitus NAILYA ASFANDIYAROVA, NINA KOLCHEVA, IGOR RYAZANT-SEV, VLADIMIRRYAZANTSEV
27. Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview, Sarah E. Capes, Dereck Hunt, Klas Malmberg, Parbeen Pathak and Hertzel C.Gerstein.